Cynthia Gauger
Pediatric Hematology-Oncology · Jacksonville, FLNPI 1417048422
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.6% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $879 and has fallen 96.1% since, to $34 in 2024.
Across 67 payments — averaging $32.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$415
- AstraZeneca$317
- Novartis$249
- Pfizer$245
- Novo Nordisk$238
- Sobi, Inc$157
- plus $589 from 11 others
Across 47 payments — averaging $2992.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bioverativ Therapeutics Inc.$50K
- Sanofi US Services Inc.$50K
- Bayer$34K
- Daiichi Sankyo Inc.$7K
What the payments were for
- Food & beverage$2,06994%
- Education$1426%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 12 | $415 |
| AstraZeneca(2 entities) | 12 | $317 |
| Novartis | 8 | $249 |
| Pfizer | 4 | $245 |
| Novo Nordisk | 11 | $238 |
| Sobi, Inc | 5 | $157 |
| Bio Products Laboratory USA, Inc. | 1 | $130 |
| CSL Behring | 1 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $107 |
| Octapharma USA, Inc. | 1 | $82 |
| Duchesnay USA Incorporated | 3 | $51 |
| Biomarin Pharmaceutical Inc. | 1 | $30 |
| Bayer | 2 | $27 |
| Aptevo Therapeutics Inc | 1 | $17 |
| Genentech, Inc. | 1 | $16 |
| Servier Pharmaceuticals LLC | 1 | $15 |
| Emmaus Medical, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,211 in reported general payments places this provider in the 65th percentile of 132 pediatric hematology-oncology providers in Florida.
See all pediatric hematology-oncology providers in Florida →
Other pediatric hematology-oncology in Jacksonville
- Howard KatzensteinJacksonville$12K
- Manisha BansalJacksonville$3K
- Darren KlawinskiJacksonville$3K
- Michael JoyceJacksonville$1K
- Scott BradfieldJacksonville$906
- Allison BechtelJacksonville$695
- Guillermo DeanguloMiami$929K
- Shveta GuptaOrlando$714K
- Joanna DavisMiami$411K
- Fernando Corrales-MedinaMiami$335K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.